BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23184730)

  • 1. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
    Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
    Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
    Kim TH; Kim YK; Woo JS
    Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P; Dolezel P; Kosztyu P
    J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
    Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
    Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
    Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
    Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.
    Jafari SM; Panjehpour M; Aghaei M; Joshaghani HR; Enderami SE
    J Cell Biochem; 2017 Sep; 118(9):2909-2920. PubMed ID: 28230290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the A3 adenosine receptor affects cell cycle progression and cell growth.
    Brambilla R; Cattabeni F; Ceruti S; Barbieri D; Franceschi C; Kim YC; Jacobson KA; Klotz KN; Lohse MJ; Abbracchio MP
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):225-34. PubMed ID: 10731034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.
    Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y
    Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
    Kim GD; Oh J; Jeong LS; Lee SK
    Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
    Mlejnek P; Dolezel P
    Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation.
    Sandhu H; Cooper S; Hussain A; Mee C; Maddock H
    Eur J Pharmacol; 2017 Nov; 814():95-105. PubMed ID: 28811127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
    Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Leung E; Maclennan S; Borea PA
    J Biol Chem; 2005 May; 280(20):19516-26. PubMed ID: 15774470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
    Hussain A; Gharanei AM; Nagra AS; Maddock HL
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
    Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK
    Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neurons.
    Coppi E; Cherchi F; Fusco I; Failli P; Vona A; Dettori I; Gaviano L; Lucarini E; Jacobson KA; Tosh DK; Salvemini D; Ghelardini C; Pedata F; Di Cesare Mannelli L; Pugliese AM
    Pain; 2019 May; 160(5):1103-1118. PubMed ID: 31008816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
    Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.
    Baltos JA; Paoletta S; Nguyen AT; Gregory KJ; Tosh DK; Christopoulos A; Jacobson KA; May LT
    Mol Pharmacol; 2016 Jul; 90(1):12-22. PubMed ID: 27136943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines.
    Joshaghani HR; Jafari SM; Aghaei M; Panjehpour M; Abedi H
    J Cancer Res Ther; 2017; 13(1):107-112. PubMed ID: 28508842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of p42/p44 mitogen-activated protein kinase by the human adenosine A3 receptor in transfected CHO cells.
    Graham S; Combes P; Crumiere M; Klotz KN; Dickenson JM
    Eur J Pharmacol; 2001 May; 420(1):19-26. PubMed ID: 11412835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.